SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Revenue of SIGA Technologies, Inc. (SIGA)
Revenue in 2023 (TTM): $139.92 M
According to SIGA Technologies, Inc.'s latest financial reports the company's current revenue (TTM) is $139.92 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of SIGA Technologies, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $139.92 M | $122.09 M | $84.16 M | $87.78 M | $68.07 M |
| 2022 | $110.78 M | $77.82 M | $43.22 M | $44.13 M | $33.9 M |
| 2021 | $133.67 M | $107.13 M | $89.62 M | $89.31 M | $69.45 M |
| 2020 | $124.96 M | $99.22 M | $85.03 M | $73.51 M | $56.34 M |
| 2019 | $26.74 M | $11.66 M | $1.03 M | $-10,178,423 | $-7,241,147 |
| 2018 | $477.05 M | $368.77 M | $355.17 M | $411.64 M | $421.81 M |
| 2017 | $12.27 M | $-4,410,752 | $-23,438,943 | $-38,329,274 | $-36,235,484 |
| 2016 | $14.99 M | $-4,723,045 | $-25,445,388 | $-39,684,076 | $-39,697,960 |
| 2015 | $8.18 M | $-4,954,651 | $-38,475,260 | $-38,989,341 | $-39,451,324 |
| 2014 | $3.14 M | $-7,690,496 | $-211,127,504 | $-211,934,870 | $-265,463,138 |
| 2013 | $5.52 M | $-8,337,200 | $-23,125,300 | $-24,795,772 | $-17,177,333 |
| 2012 | $8.97 M | $-9,242,201 | $-21,779,957 | $-22,372,306 | $-14,528,153 |
| 2011 | $12.73 M | $12.73 M | $-21,869,183 | $-22,437,470 | $13.59 M |
| 2010 | $19.22 M | $19.22 M | $-27,569,993 | $-19,400,000 | $-28,195,339 |
| 2009 | $13.81 M | $13.81 M | $-11,403,836 | $-17,617,939,000 | $-17,617,939 |
| 2008 | $8.07 M | $8.07 M | $-8,277,029 | $-8,599,377 | $-8,599,377 |
| 2007 | $6.7 M | $6.7 M | $-6,214,159 | $-5,638,557 | $-5,638,557 |
| 2006 | $7.26 M | $7.26 M | $-5,254,872 | $-9,898,708 | $-9,898,708 |
| 2005 | $8.48 M | $8.48 M | $-1,204,968 | $-2,287,550 | $-2,287,550 |
| 2004 | $1.84 M | $1.84 M | $-8,319,066 | $-12,059,867 | $-9,373,319 |
| 2003 | $731.74 K | $731.74 K | $-4,555,336 | $-5,431,646 | $-5,276,640 |
| 2002 | $344.45 K | $344.45 K | $-3,048,056 | $ | $-3,331,027 |
| 2001 | $1.16 M | $1.16 M | $-2,704,965 | $-3,654,191 | $-3,729,606 |
| 2000 | $483.12 K | $1.43 M | $-6,138,133 | $-7,239,125 | $-7,789,589 |
| 1999 | $500 K | $900 K | $-3,080,439 | $ | $-3,600,000 |
| 1998 | $500 K | $700 K | $-5,000,000 | $-6,500,000 | $-6,600,000 |
| 1997 | $700 K | $700 K | $-1,800,000 | $ | $-2,200,000 |
| 1996 | $100 K | $100 K | $-500,000 | $-2,300,000 | $-2,300,000 |